Your search returned 2 results.

Results
	1.	Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada. [electronic resource] by Moshyk, A Martel, M-J Tahami Monfared, A A Goeree, R Producer: 20161017 In: Journal of medical economics vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes. [electronic resource] by Gibson, E J Begum, N Koblbauer, I Dranitsaris, G Liew, D McEwan, P Tahami Monfared, A A Yuan, Y Juarez-Garcia, A Tyas, D Lees, M Publication details: ClinicoEconomics and outcomes research : CEOR 2018 In: ClinicoEconomics and outcomes research : CEOR vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search